Kalvista Pharmaceuticals Inc (KALV)
Net Income Growth
24.54%
TTM · Period ending:
KALV Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported24.54%period ending
Latest reported24.54%period ending
KALV TTM Net Income YoY % (-142.60% → 24.54%)
Year-over-year change
High-resolution chart · PNG
KALV net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 24.5353% | |
| -5.3574% | |
| -34.4815% | |
| -43.2595% | |
| -44.8517% | |
| -62.3906% | |
| -55.4939% | |
| -48.9462% | |
| -36.3127% | |
| -19.3849% | |
| -9.4646% | |
| -6.6202% | |
| -12.8347% | |
| -23.9581% | |
| -51.2088% | |
| -73.2125% | |
| -78.0534% | |
| -93.2351% | |
| -63.7155% | |
| -58.1339% | |
| -58.8268% | |
| -21.9396% | |
| -44.2872% | |
| -40.9445% | |
| -39.8732% | |
| -139.8857% | |
| -80.8295% | |
| -45.37% | |
| -31.7052% | |
| 33.0904% | |
| 34.6278% | |
| 5.1687% | |
| -11.2167% | |
| -16.454% | |
| -48.7253% | |
| 14.5143% | |
| 45.902% | |
| 33.124% | |
| 38.785% | |
| 14.3331% | |
| -58.9364% | |
| -85.987% | |
| -142.6005% |